Potential New Cancer Treatment Activates Cancer-Engulfing Cells: Figures 1 & 2 (IMAGE)
Caption
Figure 1: The engulfing function of the macrophage in response to cancer cells is inhibited by CD47-SIRPα interaction. Figure 2: Anti-SIRPα antibodies strengthen the tumor-killing effects of targeted drugs (A) Tumor-killing effects of rituximab strengthened by anti-SIRPα antibodies in a subcutaneous human B-cell lymphoma (Raji) model in immunodeficient mice (B) A model of how the tumor-killing effects of targeted drugs are strengthened by anti-SIRPα antibodies
Credit
Kobe University
Usage Restrictions
None
License
Licensed content